These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9640546)

  • 1. The safety of bleaching creams containing hydroquinone.
    Fisher AA
    Cutis; 1998 Jun; 61(6):303-4. PubMed ID: 9640546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxicological aspects and health risks associated with hydroquinone in skin bleaching formula].
    Kooyers TJ; Westerhof W
    Ned Tijdschr Geneeskd; 2004 Apr; 148(16):768-71. PubMed ID: 15129564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cosmetic ochronosis caused by bleaching creams containing 2% hydroquinone.
    Weiss RM; del Fabbro E; Kolisang P
    S Afr Med J; 1990 Apr; 77(7):373. PubMed ID: 2321111
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperpigmentation following the use of bleaching creams. Localized exogenous ochronosis.
    Connor T; Braunstein B
    Arch Dermatol; 1987 Jan; 123(1):105-6, 108. PubMed ID: 3800410
    [No Abstract]   [Full Text] [Related]  

  • 5. Exogenous ochronosis.
    Martín RF; Sánchez JL; González A; Lugo-Somolinos A; Ruiz H
    P R Health Sci J; 1992 Apr; 11(1):23-6. PubMed ID: 1603931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukoderma from bleaching creams containing 2% hydroquinone.
    Fisher AA
    Contact Dermatitis; 1982 Jul; 8(4):272-3. PubMed ID: 7105694
    [No Abstract]   [Full Text] [Related]  

  • 7. Can bleaching creams containing 2% hydroquinone produce leukoderma?
    J Am Acad Dermatol; 1982 Jul; 7(1):134-5. PubMed ID: 7107994
    [No Abstract]   [Full Text] [Related]  

  • 8. The safety of hydroquinone.
    Nordlund JJ; Grimes PE; Ortonne JP
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):781-7. PubMed ID: 16898897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists.
    Chandra M; Levitt J; Pensabene CA
    Acta Derm Venereol; 2012 May; 92(3):232-5. PubMed ID: 22002814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nail staining from hydroquinone cream.
    Ozluer SM; Muir J
    Australas J Dermatol; 2000 Nov; 41(4):255-6. PubMed ID: 11105373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks.
    Hoshaw RA; Zimmerman KG; Menter A
    Arch Dermatol; 1985 Jan; 121(1):105-8. PubMed ID: 3966811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous ochronosis from hydroquinone bleaching cream.
    Fisher AA
    Cutis; 1998 Jul; 62(1):11-2. PubMed ID: 9675524
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reasons for consulting related to skin-bleaching products used by 104 women in Brazzaville].
    Gathse A; Obengui ; Ibara JR
    Bull Soc Pathol Exot; 2005 Dec; 98(5):387-9. PubMed ID: 16425720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams.
    Findlay GH; Morrison JG; Simson IW
    Br J Dermatol; 1975 Dec; 93(6):613-22. PubMed ID: 1220808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ochronosis following skin bleaching with hydroquinone.
    Findlay GH
    J Am Acad Dermatol; 1982 Jun; 6(6):1092-3. PubMed ID: 7096673
    [No Abstract]   [Full Text] [Related]  

  • 18. Exogenous ochronosis and striae atrophicae following the use of bleaching creams.
    Bongiorno MR; Aricò M
    Int J Dermatol; 2005 Feb; 44(2):112-5. PubMed ID: 15689207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of idiopathic vitiligo from contact leukoderma. Part II: Leukoderma due to cosmetics and bleaching creams.
    Fisher AA
    Cutis; 1994 May; 53(5):232-4. PubMed ID: 8039412
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of allergy to food proteins in topical medicinal agents and cosmetics.
    Codreanu F; Morisset M; Cordebar V; Kanny G; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2006 Apr; 38(4):126-30. PubMed ID: 16805419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.